[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617690":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":34,"centralContacts":51,"locations":57,"responsibleParty":130,"collaborators":30,"id":132,"slug":133,"hasResults":134,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":138,"eligibilityCriteria":139,"healthyVolunteers":134,"sex":140,"minAge":141,"maxAge":30,"enrollmentInfo":142,"targetDuration":30,"studyType":145,"phases":146,"briefSummary":148,"conditions":149,"keywords":151,"overallStatus":60,"whyStopped":30,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":165,"completionDateStruct":167,"leadSponsor":169,"locationsCount":170},{"fullName":5,"class":6},"Medtronic Cardiovascular","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Medtronic Intrepid™ TTVR","EXPERIMENTAL","Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.",[13],"Device: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System",{"label":15,"type":16,"description":17,"interventionNames":18},"Edwards EVOQUE TTVR","ACTIVE_COMPARATOR","Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.",[19],"Device: Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System",{"label":21,"type":10,"description":22,"interventionNames":23},"Single Arm Registry","Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.",[13],[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DEVICE","Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System","Transcatheter Tricuspid Valve Replacement",[9,21],null,{"type":26,"name":32,"description":28,"armGroupLabels":33,"otherNames":30},"Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System",[15],[35,39,42,45,48],{"name":36,"affiliation":37,"role":38},"Vinayak N. Bapat, MD","Minneapolis Heart Institute","PRINCIPAL_INVESTIGATOR",{"name":40,"affiliation":41,"role":38},"Anita Asgar, MD","Northwestern Medicine Bluhm Cardiovascular Institute",{"name":43,"affiliation":44,"role":38},"Nicolas Dumonteil, MD","Clinique Pasteur Groupe CardioVasculaire Interventionnel",{"name":46,"affiliation":47,"role":38},"Azeem Latib, MD","Montefiore Medical Center",{"name":49,"affiliation":50,"role":38},"Firas Zahr, MD","Knight Cardiovascular Institute",[52],{"name":53,"role":54,"phone":55,"phoneExt":30,"email":56},"Amber St Martin","CONTACT","612-380-5637","rs.pathfinder@medtronic.com",[58,79,96,113],{"facility":59,"status":60,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Abrazo Arizona Heart Hospital","RECRUITING","Phoenix","Arizona","85016","United States","US",{"type":67,"coordinates":68},"Point",[69,70],-112.07404,33.44838,{"lat":70,"lon":69},[73,77],{"name":74,"role":54,"phone":75,"phoneExt":30,"email":76},"Jesica Byrne","602-952-0002","jessica.byrne@abrazohealth.com",{"name":78,"role":38,"phone":30,"phoneExt":30,"email":30},"Timothy Byrne, MD",{"facility":80,"status":60,"city":81,"state":82,"zip":83,"country":64,"countryCode":65,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Los Robles Hospital & Medical Center","Thousand Oaks","California","91360",{"type":67,"coordinates":85},[86,87],-118.83759,34.17056,{"lat":87,"lon":86},[90,94],{"name":91,"role":54,"phone":92,"phoneExt":30,"email":93},"Jason Yashar","805-796-5881","jason.yashar@hcahealthcare.com",{"name":95,"role":38,"phone":30,"phoneExt":30,"email":30},"Saibal Kar, MD",{"facility":97,"status":60,"city":98,"state":99,"zip":100,"country":64,"countryCode":65,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"Abbott Northwestern Hospital","Minneapolis","Minnesota","55407",{"type":67,"coordinates":102},[103,104],-93.26384,44.97997,{"lat":104,"lon":103},[107,111],{"name":108,"role":54,"phone":109,"phoneExt":30,"email":110},"Jennifer Nguyen","612-863-9291","jennifer.nguyen@allina.com",{"name":112,"role":38,"phone":30,"phoneExt":30,"email":30},"Konstantinos Voudris, MD",{"facility":114,"status":60,"city":115,"state":116,"zip":117,"country":64,"countryCode":65,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"The Christ Hospital","Cincinnati","Ohio","45219",{"type":67,"coordinates":119},[120,121],-84.51439,39.12711,{"lat":121,"lon":120},[124,128],{"name":125,"role":54,"phone":126,"phoneExt":30,"email":127},"Jamie Elkins","513-585-1640","jamie.elkins@thechristhospital.com",{"name":129,"role":38,"phone":30,"phoneExt":30,"email":30},"Puvi Seshiah, MD",{"type":131,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100617690","transcatheter-tricuspid-valve-replacement-with-the-medtronic-intrepid-transcatheter-tricuspid-valve-replacement-ttvr-system-in-severe-tricuspid-regurgitation-100617690",false,"NCT07321899","Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation","Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER","PATHFINDER","Inclusion Criteria:\n\n* Age ≥18 years at the time of consent.\n* Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT).\n* Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR.\n\nExclusion Criteria:\n\n* Any tricuspid device currently in place.\n* Anatomic contraindications.\n* Need for emergent or urgent surgery.\n* Left ventricular ejection fraction \\\u003C25%.","ALL","18 Years",{"count":143,"type":144},1186,"ESTIMATED","INTERVENTIONAL",[147],"NA","This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.",[150],"Severe Tricuspid Regurgitation",[152,153,154,155,156,157,158,159,160],"Tricuspid Regurgitation","Symptomatic tricuspid regurgitation","Heart valve disease","Structural heart intervention","Severe valve disease","Randomized controlled trial","tricuspid insufficiency","tricuspid disease","tricuspid valve disease","2026-07-27",{"date":163,"type":164},"2026-07-28","ACTUAL",{"date":166,"type":144},"2026-08",{"date":168,"type":144},"2041-04",{"name":5,"class":6},4]